Paul OConnell - Vascular Solutions Insider

Vascular Solutions Inc -- USA Stock  

USD 56  0.00  0.00%

Independent Director

Mr. Paul OConnell is an Independent Director of Vascular Solutions, Inc., since January 29, 2002. He In January of 2014, Mr. OConnell became President of B. Braun CeGat, a genomic sequencing and diagnostic company providing services to clinicians and hospitals in the United States. Since 2001, Mr. OConnell has also been serving as President of B. Braun Interventional Systems, Inc., a wholly owned subsidiary of B. Braun Melsungen AG, a global supplier of products for anesthesia, intensive medicine, cardiology, extra corporeal blood treatment and surgery as well as services for hospitals, general practitioners and the homecare sector. Mr. OConnell was previously Vice President of the Vascular Interventional Products Group of B. Braun Medical, an international medical device company, from 1989 to 2001. In addition, from 1999 through 2001, Mr. OConnell provided marketing and technical support consulting services to medical device companies. Mr. OConnell was the owner of Sablier, a medical device company, from 1998 through 1999 where he developed new technologies for the treatment of thromboembolic diseases and for distal protection during carotid endarterectomy. From 1993 through 1998, Mr. OConnell was Vice President and General Manager of the Vena Tech division of B. Braun Medical, a medical device business he originally cofounded in 1988 and sold to B. Braun Medical in 1993. Through more than 20 years of experience as the General Manager or President of growthoriented medical device companies within cardiology and radiology fields of practice,
Age: 61  Director Since 2002      
877 656-4251  www.vasc.com

Paul OConnell Latest Insider Activity

Management Efficiency

The company has return on total asset (ROA) of 6.28 % which means that it generated profit of $6.28 on every $100 spent on asset. This is normal as compared to the sector avarege.
The company currently holds 867 K in liabilities with Debt to Equity (D/E) ratio of 0.13 which may suggest the company is not taking enough advantage from borrowing. Vascular Solutions Inc has Current Ratio of 6.24 suggesting that it is liquid enough and is able to pay its financial obligations when they are due.

Similar Executives

Showing few of many executives

DIRECTOR Since

Leslie HeiszEdwards Lifesciences Corporatio
2016
Malcolm HoenleinDarioHealth Corp
2011
Wesley SchackEdwards Lifesciences Corporatio
2012
Kieran GallahueEdwards Lifesciences Corporatio
2015
John ClimacoDigirad Corporation
2012
John CardisEdwards Lifesciences Corporatio
2004
Steven LorangerEdwards Lifesciences Corporatio
2016
Dennis McGrathDarioHealth Corp
2013
Michael CunnionDigirad Corporation
2014
Richard StoneDarioHealth Corp
2014
Rami YehudihaDarioHealth Corp
2014
Charles GillmanDigirad Corporation
2012
Yossi BahagonDarioHealth Corp
2017
Yalon FarhiDarioHealth Corp
2016
Barbara McNeilEdwards Lifesciences Corporatio
2006
Dimitrios AngelisDigirad Corporation
2015
William LinkEdwards Lifesciences Corporatio
John SaywardDigirad Corporation
2008
Hila KarahDarioHealth Corp
2014
Nicholas ValerianiEdwards Lifesciences Corporatio
2014
Allen KamerDarioHealth Corp
2017

Entity Summary

Vascular Solutions, Inc., a medical device company, offer clinical solutions for treating coronary and peripheral vascular disease worldwide. Vascular Solutions Inc (VASC) is traded on NASDAQ in USA. It is located in MINNESOTA, U.S.A and employs 568 people. Vascular Solutions is listed under Medical Equipment category by Fama And French industry classification.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Vascular Solutions Inc to your portfolio

Top Management

Vascular Solutions Inc Leadership Team

Stock Performance

Vascular Solutions Performance Indicators